Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism

Mike Georgiou, Ati Gonenc, Drenna Waldrop-Valverde, Russ A. Kuker, Shabbir Ezuddin, George N Sfakianakis, Mahendra Kumar

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Injecting drug use (IDU) is a major risk factor for contracting HIV-1 infection. Both HIV and IDU are neurotoxic, and their coexistence may lead to increased dysfunction of brain metabolic processes. The objective of this research was to investigate the effects of HIV-1 infection and IDU on 18F-FDG PET brain metabolism. Methods: 18F-FDG PET brain imaging, with a standard clinical protocol, was performed on 59 subjects who belonged to 3 groups: HIV-positive/IDU-positive (n = 17), HIV-negative/IDU- positive (n = 13), and HIV-negative/IDU-negative controls (n = 29). A voxel-based analysis of the 18F-FDG PET brain images was performed using statistical parametric mapping. The imageswere spatially normalized to a standard 18F-FDG template, proportionally scaled to compensate for count differences, and then appropriately smoothed. Statistical 2-sample t tests were performed to determine regional metabolic distribution differences in the 3 groups. Results: Diffuse hypermetabolism in the subcortical and deep white matter, the basal ganglia, and the thalami was observed in HIV-1 infection. IDU resulted in increased brainstem metabolism and decreased activity in cortical structures including bilateral medial frontal lobes and the right inferior frontal and temporal cortices. The cortical hypometabolism was more extensive in HIV-1-infected subjects, involving the left temporoparietal and right parietal cortices and bilateral medial frontal lobes. Conclusion: Voxel-based analysis of 18F-FDG PET brain images demonstrated statistically significant differences in regional metabolism for the 3 studied groups. It also showed that HIV-1 infection may have a synergistic effect with IDU, resulting in more extensive cortical hypometabolism. Correlation of these findings with other quantitative approaches and neurocognitive functioning is warranted.

Original languageEnglish
Pages (from-to)1999-2005
Number of pages7
JournalJournal of Nuclear Medicine
Volume49
Issue number12
DOIs
StatePublished - Dec 1 2008

Fingerprint

Fluorodeoxyglucose F18
HIV Infections
HIV-1
Brain
Pharmaceutical Preparations
Frontal Lobe
HIV
Parietal Lobe
Temporal Lobe
Clinical Protocols
Basal Ganglia
Thalamus
Neuroimaging
Brain Stem
Research

Keywords

  • F-FDG PET brain imaging
  • HIV-1 infection
  • Injecting drug use
  • Statistical parametric mapping

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism. / Georgiou, Mike; Gonenc, Ati; Waldrop-Valverde, Drenna; Kuker, Russ A.; Ezuddin, Shabbir; Sfakianakis, George N; Kumar, Mahendra.

In: Journal of Nuclear Medicine, Vol. 49, No. 12, 01.12.2008, p. 1999-2005.

Research output: Contribution to journalArticle

Georgiou, Mike ; Gonenc, Ati ; Waldrop-Valverde, Drenna ; Kuker, Russ A. ; Ezuddin, Shabbir ; Sfakianakis, George N ; Kumar, Mahendra. / Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism. In: Journal of Nuclear Medicine. 2008 ; Vol. 49, No. 12. pp. 1999-2005.
@article{39eed44c78e6427d82fa82fe6d5ada70,
title = "Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism",
abstract = "Injecting drug use (IDU) is a major risk factor for contracting HIV-1 infection. Both HIV and IDU are neurotoxic, and their coexistence may lead to increased dysfunction of brain metabolic processes. The objective of this research was to investigate the effects of HIV-1 infection and IDU on 18F-FDG PET brain metabolism. Methods: 18F-FDG PET brain imaging, with a standard clinical protocol, was performed on 59 subjects who belonged to 3 groups: HIV-positive/IDU-positive (n = 17), HIV-negative/IDU- positive (n = 13), and HIV-negative/IDU-negative controls (n = 29). A voxel-based analysis of the 18F-FDG PET brain images was performed using statistical parametric mapping. The imageswere spatially normalized to a standard 18F-FDG template, proportionally scaled to compensate for count differences, and then appropriately smoothed. Statistical 2-sample t tests were performed to determine regional metabolic distribution differences in the 3 groups. Results: Diffuse hypermetabolism in the subcortical and deep white matter, the basal ganglia, and the thalami was observed in HIV-1 infection. IDU resulted in increased brainstem metabolism and decreased activity in cortical structures including bilateral medial frontal lobes and the right inferior frontal and temporal cortices. The cortical hypometabolism was more extensive in HIV-1-infected subjects, involving the left temporoparietal and right parietal cortices and bilateral medial frontal lobes. Conclusion: Voxel-based analysis of 18F-FDG PET brain images demonstrated statistically significant differences in regional metabolism for the 3 studied groups. It also showed that HIV-1 infection may have a synergistic effect with IDU, resulting in more extensive cortical hypometabolism. Correlation of these findings with other quantitative approaches and neurocognitive functioning is warranted.",
keywords = "F-FDG PET brain imaging, HIV-1 infection, Injecting drug use, Statistical parametric mapping",
author = "Mike Georgiou and Ati Gonenc and Drenna Waldrop-Valverde and Kuker, {Russ A.} and Shabbir Ezuddin and Sfakianakis, {George N} and Mahendra Kumar",
year = "2008",
month = "12",
day = "1",
doi = "10.2967/jnumed.108.052688",
language = "English",
volume = "49",
pages = "1999--2005",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "12",

}

TY - JOUR

T1 - Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism

AU - Georgiou, Mike

AU - Gonenc, Ati

AU - Waldrop-Valverde, Drenna

AU - Kuker, Russ A.

AU - Ezuddin, Shabbir

AU - Sfakianakis, George N

AU - Kumar, Mahendra

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Injecting drug use (IDU) is a major risk factor for contracting HIV-1 infection. Both HIV and IDU are neurotoxic, and their coexistence may lead to increased dysfunction of brain metabolic processes. The objective of this research was to investigate the effects of HIV-1 infection and IDU on 18F-FDG PET brain metabolism. Methods: 18F-FDG PET brain imaging, with a standard clinical protocol, was performed on 59 subjects who belonged to 3 groups: HIV-positive/IDU-positive (n = 17), HIV-negative/IDU- positive (n = 13), and HIV-negative/IDU-negative controls (n = 29). A voxel-based analysis of the 18F-FDG PET brain images was performed using statistical parametric mapping. The imageswere spatially normalized to a standard 18F-FDG template, proportionally scaled to compensate for count differences, and then appropriately smoothed. Statistical 2-sample t tests were performed to determine regional metabolic distribution differences in the 3 groups. Results: Diffuse hypermetabolism in the subcortical and deep white matter, the basal ganglia, and the thalami was observed in HIV-1 infection. IDU resulted in increased brainstem metabolism and decreased activity in cortical structures including bilateral medial frontal lobes and the right inferior frontal and temporal cortices. The cortical hypometabolism was more extensive in HIV-1-infected subjects, involving the left temporoparietal and right parietal cortices and bilateral medial frontal lobes. Conclusion: Voxel-based analysis of 18F-FDG PET brain images demonstrated statistically significant differences in regional metabolism for the 3 studied groups. It also showed that HIV-1 infection may have a synergistic effect with IDU, resulting in more extensive cortical hypometabolism. Correlation of these findings with other quantitative approaches and neurocognitive functioning is warranted.

AB - Injecting drug use (IDU) is a major risk factor for contracting HIV-1 infection. Both HIV and IDU are neurotoxic, and their coexistence may lead to increased dysfunction of brain metabolic processes. The objective of this research was to investigate the effects of HIV-1 infection and IDU on 18F-FDG PET brain metabolism. Methods: 18F-FDG PET brain imaging, with a standard clinical protocol, was performed on 59 subjects who belonged to 3 groups: HIV-positive/IDU-positive (n = 17), HIV-negative/IDU- positive (n = 13), and HIV-negative/IDU-negative controls (n = 29). A voxel-based analysis of the 18F-FDG PET brain images was performed using statistical parametric mapping. The imageswere spatially normalized to a standard 18F-FDG template, proportionally scaled to compensate for count differences, and then appropriately smoothed. Statistical 2-sample t tests were performed to determine regional metabolic distribution differences in the 3 groups. Results: Diffuse hypermetabolism in the subcortical and deep white matter, the basal ganglia, and the thalami was observed in HIV-1 infection. IDU resulted in increased brainstem metabolism and decreased activity in cortical structures including bilateral medial frontal lobes and the right inferior frontal and temporal cortices. The cortical hypometabolism was more extensive in HIV-1-infected subjects, involving the left temporoparietal and right parietal cortices and bilateral medial frontal lobes. Conclusion: Voxel-based analysis of 18F-FDG PET brain images demonstrated statistically significant differences in regional metabolism for the 3 studied groups. It also showed that HIV-1 infection may have a synergistic effect with IDU, resulting in more extensive cortical hypometabolism. Correlation of these findings with other quantitative approaches and neurocognitive functioning is warranted.

KW - F-FDG PET brain imaging

KW - HIV-1 infection

KW - Injecting drug use

KW - Statistical parametric mapping

UR - http://www.scopus.com/inward/record.url?scp=57149118871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149118871&partnerID=8YFLogxK

U2 - 10.2967/jnumed.108.052688

DO - 10.2967/jnumed.108.052688

M3 - Article

C2 - 18997046

AN - SCOPUS:57149118871

VL - 49

SP - 1999

EP - 2005

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 12

ER -